Radiation Therapy after Radical Prostatectomy: Implications for Clinicians.

Area of Science:

• Oncology
• Urology
• Radiation Oncology

Background:

• Radical prostatectomy (RP) is a primary treatment for prostate cancer.
• Up to 60% of patients experience biochemical relapse post-RP, necessitating further treatment.
• High-risk pathological features after RP indicate a greater risk of recurrence.

Purpose of the Study:

• To evaluate the efficacy of immediate adjuvant radiotherapy (RT) versus observation or salvage RT after RP.
• To address the dilemma of overtreatment versus optimal timing of RT in high-risk prostate cancer patients.
• To inform clinical decision-making regarding adjuvant RT based on pathological findings and PSA levels.

Main Methods:

• Review of published randomized trials and retrospective analyses concerning adjuvant and salvage radiotherapy.
• Analysis of survival outcomes (biochemical, clinical progression-free, and overall survival).
• Consideration of ongoing randomized trials investigating optimal RT strategies.

Main Results:

• Immediate adjuvant RT improves survival outcomes in high-risk prostate cancer patients.
• Current practice may lead to overtreatment in approximately 50% of patients, causing unnecessary toxicity and costs.
• Retrospective data suggest a dose-response relationship favoring doses >70 Gy to the prostate bed.

Conclusions:

• The optimal timing for radiotherapy (immediate adjuvant vs. early salvage) after radical prostatectomy remains under investigation.
• Balancing the benefits of early intervention against the risks of overtreatment is crucial in managing high-risk prostate cancer.
• Further evidence is needed, particularly from ongoing randomized trials, to refine treatment guidelines.